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1220Objectives: The characteristic morphologic lesions observed in the lungs of patients with congenital cardiac
anomalies have not been closely modeled in rat shunt-related models, except for the reversible grade 1 changes.
The present study reported an original rat model of unilateral pulmonary hypertension surgically induced by
combined surgery to reproduce more advanced pulmonary vascular lesions.
Methods: The right pulmonary artery was ligated through a right posterolateral thoracotomy, and a cervical
shunt was established 1 week later. The immediate and chronic effects on the pulmonary hemodynamics
were evaluated through right heart catheterization immediately after and at 8 and 12 weeks postoperatively.
The morphologic changes in pulmonary vasculature were analyzed after staining with hematoxylin-eosin and
modified Weigert’s method. The right ventricular hypertrophy index was calculated and artery blood gas anal-
ysis performed.
Results:A pulmonary hypertensive status was successfully induced immediately after cervical surgery and pro-
gressively aggravated into a borderline state with disease course advancing. Pulmonary vasculopathy demon-
strated a transition from reversibility (muscularization, intimal proliferation of grade 1-2) at 8 weeks to
irreversibility (intimal fibrosis, entirely luminal occlusion, grade 3) at 12 weeks postoperatively. Conspicuous
right ventricular hypertrophy and decreasing partial arterial pressure of oxygen were also observed.
Conclusions: The present shunt-related model successfully simulated a hypertensive status in pulmonary circu-
lation and reproduced the characteristic transition of pulmonary vasculopathy from reversibility to irreversibility
within a relatively short period. Thus, this model could offer an alternative with low mortality and high repro-
ducibility for investigations on the underling mechanisms of shunt-related pulmonary hypertension. (J Thorac
Cardiovasc Surg 2013;146:1220-6)Supplemental material is available online.
In patients with systemic-to-pulmonary shunts, the status of
the pulmonary vascular structure and the extent of pulmo-
nary hypertension (PH) are important determinants of the
feasibility of corrective procedures, the clinical course,
and long-term survival. Recently, drugs targeting the signal-
ing pathways involved in the pathogenesis of PH have been
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The Journal of Thoracic and Cardiovascular Surmonocrotaline-induced PH in rats. However, these targeted
drugs only exhibited partial improvements in symptoms,
exercise tolerance, and hemodynamic indexes, with slight
efficacy on mortality in patients with severe PH.1 This has
largely attenuated the dogma that the hypoxia/
monocrotaline-induced PH model should be used to delin-
eate the potential mechanism of PH, including shunt-
related PH1-3 and thus would be the most scientific
method for determining the underlying mechanism of
hyperkinetic PH in experimentally validated shunt-related
models.
Many shunt-related models have been described and
studied. These have included peripheral shunts established
in the cervical,4 abdominal,5 or femoral6 unit and central
shunts prepared between the left innominate artery,7 left ca-
rotid artery,8 or ascending aorta9 and pulmonary artery
trunk. However, peripheral shunts have only induced lim-
ited pulmonary vascular remodeling (reversible grade 1).
The high-level surgical requirements, relatively greater
mortality,10 and inadequacy of biochemical reagents for
large animals have impeded the adoption of central shunt
models; thus, an acceptable shunt-related model is still
lacking.
Therefore, we created an original, reproducible, shunt-
related model in rats using a 2-stage surgical procedure.gery c November 2013
Abbreviations and Acronyms
CSG ¼ combined surgery group
LCCA ¼ left common carotid artery
LCSG ¼ left cervical shunt group
LEJV ¼ left external jugular vein
mPAP ¼ mean pulmonary arterial pressure
MT ¼ medial thickness
PASP ¼ pulmonary arterial systolic pressure
PH ¼ pulmonary hypertension
RPALG ¼ right pulmonary artery ligation group
RVHI ¼ right ventricular hypertrophy index
RVSP ¼ right ventricular systolic pressure
SD ¼ Sprague-Dawley
SOG ¼ sham operation group
Meng et al Evolving Technology/Basic ScienceSubsequently, we performed hemodynamics evaluation,
morphologic analysis, and blood gas analysis to explore
the extent of PH achieved with this model.E
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Male Sprague-Dawley (SD) rats from Vital River Laboratory Animal
(Beijing, China) were used (age, 8 weeks; weight, 280  20 g). They
were randomly allocated to the right pulmonary artery ligation group
(RPALG, n¼ 16), left cervical shunt group (LCSG, n¼ 16), combined sur-
gery group (CSG, n ¼ 32), and sham operation group (SOG, n ¼ 24).
All rats received humane care in compliance with the ‘‘Guide for the
Care and Use of Laboratory Animals’’ (National Institutes of Health pub-
lication no. 85-23, National Academy Press, Washington, DC, revised
1996). The ethics committee on animal study of Fuwai Hospital approved
the experimental protocol.
Discrepancy in Bilateral Lungs of SD Rats
The right lung of SD rats consists of 4 lobes and the left lung of only 1
lobe. Although this unique arrangement has been attributed to the anatomic
deflection of the heart, we still needed to ascertain its true implications in
creating shunt-related PH.
Bilateral lungs of age-, gender-, and weight-matched SD rats (n ¼ 36)
were collected and individually weighed before and after oven drying at
50 for 72 hours. Next, the relationship between the bilateral lungs was
assessed by plotting the wet or dry weight of the right lung to that of the
left lung (Figure 1). The mean wet ratio was 1.96  0.11 and the mean dry
weight ratiowas 1.95 0.11.Using this anatomic discrepancy and the extant
surgical procedure (ligation of the pulmonary artery),11 we ligated the right
pulmonary artery to increase the pulmonary blood flow in the left lung.
Surgical Protocol
The rats were anesthetized with 10% chloral hydrate and atropine sul-
fate (3 mL/kg and 0.1 mg, respectively, intraperitoneally), orotracheally
intubated, and immobilized in a left lateral decubitus position. Ventilation
was maintained with a Harvard Rodent Ventilator (Inspira ASVP, Harvard
Apparatus, Holliston, Mass) for the whole procedure.
Right Pulmonary Artery Ligation Group
Under sterile conditions, the right pulmonary artery was approached
through a posterolateral thoracotomy in the third intercostal space and then
ligated (10-0 nylon suture) after dissecting the interspace between right supe-
rior vena cava and right primary bronchus (Figure 2, A). Next, the chest wasThe Journal of Thoracic and Carclosed in layers (3-0 silk suture), and all the air in the right pleural spacewas
evacuated through a tube of polyethylene 50, servingas a chest drainage tube.
Finally, the rats were weaned from mechanical ventilation and allowed to
recover with continuous supplemental oxygen. However, the endotracheal
tube was not extubated until their respiration had stabilized.
Left Cervical Shunt Group
Anesthesia was induced as described for the previous group, and sys-
temic heparinization was implemented by heparin sodium (100 IU, intra-
peritoneally). During spontaneous breathing, the rats were fixed in
a supine position, and the left common carotid artery (LCCA) and left ex-
ternal jugular vein (LEJV) were exposed. Next, the proximal LCCA was
clamped with microvascular clips and the distal portion was ligated at
the bifurcation point. The proximal LEJV was suspended to the adjacent
jugular muscle by microscopic suture, and the distal portion was ligated
at the confluence site. Subsequently, the LCCAwas amputated before the
bifurcation and immediately flushed with heparin (50 U/mL). Next, the
proximal stump was brought through and everted over a 2-mm-long,
18-gauge, intravenous catheter and circumferentially ligated in the middle
of the cuff body. Then, the proximal stump of the LCCAwas rotated and
inserted into the LEJV lumen through a transverse incision in the anterior
wall of the LEJV and the anastomosis was secured by ligatures (Figure 2,
B). Finally, the suspended suture and the vascular clips were sequentially
removed, and the patency of the shunt was confirmed visually by the pres-
ence of a continuous thrill, apparent dilation, and contradictory color
change of the proximal part of the LEJV.
Combined Surgery Group
The combined surgery was performed as a 2-stage procedure. In brief,
the right pulmonary artery was ligated, and, 1 week later, the left cervical
shunt was established (Figure 2).
Sham Operation Group
The rats in the SOGunderwent the 2-stage procedure, except for ligation
of the right pulmonary artery and generation of the cervical communication.
Postoperative Care
Postoperatively, the rats were kept in a constant-temperature room
(21C; relative humidity, 50%-70%), exposed to a normal light/dark cycle,
and provided standard laboratory chow and water ad libitum. Aspirin (75
mg/kg/d) and hydrochlorothiazide (25 mg/d) were administered by hydro-
posia to prevent anastomosis occlusion and lung edema.Hemodynamics
The pulmonary pressure changes were measured in the closed-chest rats
with a technique routinely used in our laboratory.12 In brief, a 13-cm-long,
heparin-priming polyethylene catheter (outer diameter, 0.9 mm) connected
to PowerLab 16/30 (ADInstruments, Dunedin, New Zealand) through
a pressure transducer was introduced into the right external jugular vein
and advanced into the right ventricle and the main pulmonary artery. The
right ventricular systolic pressure (RVSP), pulmonary arterial systolic
pressure (PASP), and mean pulmonary arterial pressure (mPAP) were
recorded.
Immediate effect test. The acute effects of the 4 different surgical
interventions on the pulmonary circulation were evaluated immediately
after surgery. The shunt clamping test was performed to evaluate the revers-
ibility of PH in the LCSG, CSG, and SOG.
Chronic effect test. The chronic effects of the 4 different surgical
procedures on the pulmonary vasculature were investigated at 8 and 12
weeks after the surgical intervention. The baseline data of the hemody-
namic variables before and after occlusion of the cervical shunt was
measured in the LCSG, CSG, and SOG.diovascular Surgery c Volume 146, Number 5 1221
FIGURE 1. Wet and dry weight ratio of right lung (RL)/left lung (LL) of
age-, gender-, and weight-matched Sprague-Dawley (SD) rats. Mean wet
weight ratio was 1.96  0.11 and dry weight ratio was 1.95  0.11, indi-
cating RL had more flow reversal than LL.
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A blood sample (0.3 mL) was taken from the femoral artery and
analyzed in a blood gas analyzer (Nova Biomedical, pHOx Ultra, Waltham
Mass). The partial arterial pressure of oxygen, blood oxygen saturation,
hemoglobin concentration, and hematocrit were determined.
Organ Harvesting
After the hemodynamic measurements, the left lung was perfused
with 4 phosphate-buffered saline through the inferior cava vena. Next,
the heart–lung tissues were immediately extirpated en bloc. The lower
part of the left lung was rinsed in 10% neutral-buffered formalin through
the left principal bronchus under constant pressure until fully inflated
and immersed in 10% formalin for 24 hours at room temperature. Then,
the fixed tissues were trimmed to an appropriate size, placed in embedding
cassettes, dehydrated in graded ethanol dilutions, cleared in xylene solu-
tion, and embedded in paraffin.
Morphologic Analysis
Four 4-mm-thick sections were cut from each paraffin block. Two were
stained with hematoxylin-eosin for routine light microscopic examination,FIGURE 2. A, Intraoperative photograph of first-stage procedure—ligation o
intercostal space, the RPA was exposed and ligated after mobilizing interspa
(RPB). B, Second-stage surgery—cervical shunt communication procedure. Ce
jugular vein (LEJV) was established using a cuff technique.
1222 The Journal of Thoracic and Cardiovascular Surand two were stained with modified Weigert’s method to demonstrate the
elastic tissueandcounterstainedwithVanGieson’s solution to show themus-
cle and collagen.All the smallmuscular pulmonary arteries discriminated by
the accompanying airwayswere systematically scanned for graded lesions in
the pulmonary arteries and arterioles according to the Heath–Edwards clas-
sification.13 The presence of medial hypertrophy was carefully graded
according to well-established quantitative protocols9 using an Olympus im-
aging analyzer system (Olympus BX61, Tokyo, Japan). The medial thick-
ness (MT) was determined as the mean distance between the internal and
external elastic lamina, and the percentage of MTwas calculated using the
following formula: percentage ofMT¼ 23MT/external diameter3 100%.
The pulmonary vasculopathy evaluation was performed by 1 of us
(J.M.), who did not know the source of the slides. The reversible and irre-
versible lesions were demarcated according to the standards presented by
Heath and Edwards,13 Wagenvoort,14 and Wagenvoort and colleauges.15
Muscularization (grade 1) and cellular intimal proliferation (grade 2)
were judged as reversible lesions, and intimal fibrosis and entire luminal
occlusion (grade 3) were classified as irreversible lesions.
Right Ventricular Hypertrophy Evaluation
The free wall of the right ventricle was separated from the ventricular
septum. Next, the right and left ventricles plus the septum were blotted
and weighed. Finally, the right ventricular hypertrophy index (RVHI)
was calculated as the ratio of the weight of right ventricle to that of the
left ventricle plus the septum.8
Statistical Analysis
The data are presented as the mean standard deviation. The data from
the rats in the CSG were compared with those from the rats in the RPALG,
LCSG, and SOG using SPSS, version 13.0, statistical software (SPSS, Chi-
cago, Ill). The data from the rats in the CSG and RPALG, LCSG, and SOG
were compared using independent-samples t tests. The data from the same
group before and after closure of the cervical shunt were compared using
paired-samples t tests.RESULTS
Survival
All the rats survived the operation. Three postoperative
deaths occurred in the CSG, one in the SOG, and none in
the RPALG and LCSG. A postmortem examination was
performed to ascertain the cause of death. The 3 deaths in
the CSG were from postoperative right heart failure, andf right pulmonary artery (RPA). After posterolateral thoracotomy in third
ce between right superior vena cava (SVC) and right primary bronchus
rvical shunt between left common carotid artery (LCCA) and left external
gery c November 2013
FIGURE 3. A, Right ventricular systolic pressure (RVSP) changes before (white bar) and after (solid bar) closure of cervical shunt. Mean values for RVSP
showed time-related increment in left cervical shunt group (LCSG) and combined surgery group (CSG),with significant differences between CSG and LCSG
and sham operation group (SOG) at 8 and 12 weeks postoperatively. Shunt clamping induced significant decreases in RVSP in LCSG at 8 weeks postop-
eratively (8W-L),CSG at 8 weeks postoperatively (8W-C), and LCSG at 12 weeks postoperatively (12W-L) but not in CSG at 12 weeks postoperatively (12W-
C). No significant differences were found between right pulmonary artery ligation group (RPALG) and LCSG (P>.50); thus, only RVSP in LCSG is shown.
B, Pulmonary arterial systolic pressure (PASP) changes before (open bar) and after (solid bar) closure of cervical shunt.Mean values for PASP showed time-
related increment in LCSG and CSG, with significant differences between CSG and LCSG and SOG at 8 and 12 weeks postoperatively. Shunt clamping
induced significant decreases in PASP in 8W-L, 8W-C, and 12W-L but not in 12W-C. No significant differences were found between RPALG and
LCSG (P>.50); thus, only PASP in LCSG is shown. C, Mean pulmonary arterial pressure (mPAP) changes before (open bar) and after (solid bar) closure
of cervical shunt.MeanmPAPs showed time-related increment in LCSG and CSG, with significant differences between CSG and LCSG and SOG at 8 and 12
weeks. Shunt clamping induced significant decreases in mPAP of CSG and LCSG at 8 and 12 weeks. No significant differences were found between RPALG
and LCSG (P>.50); thus, only mPAP in LCSG is shown. D, Right ventricle/left ventricle plus septum weight ratio changes in RPALG, LCSG, CSG, and
SOG. Right ventricular hypertrophy index (RVHI) in LCSG and CSG showed time-related increments, with significant differences in RVHI between CSG
and LCSG and SOG at 8 and 12 weeks. No significant differences were found between RPALG and LCSG (P>.50); thus, only mPAP in LCSG is shown.
Data presented as mean standard deviation. **P<.01, *P<.05, ##P<.01, #P<.05, and NSP>.05. 8W-S, SOG at 8 weeks postoperatively; 8W-C,CSG at
8 weeks postoperatively; 12W-S, SOG at 12 weeks postoperatively.
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maining rats survived and were all included in the final data
analysis. The total survival rate was 90.63% in the CSG.
Three rats in the CSG (1 at 8 weeks and 2 at 12 weeks)
died during right heart catheterization. Of the 3 rats, 2
died of cardiac tamponade because the catheter tip pene-
trated the right atrium wall and protruded into the pericar-
dial cavity. However, the third died of unknown reasons.
Therefore, the hemodynamic indexes were not obtained
from these animals. Otherwise, slow weight gain was
observed with high frequency in the CSG (Table E1).
Anastomosis Patency Status
At the harvesting points, most rats in the CSG and LCSG
demonstrated conspicuous pulsation and a vigorous thrill in
the left supraclavicular fossa. However, in 2 rats in the CSG,The Journal of Thoracic and Carno evident thrill was observed at 12 weeks, indicating the
presence of systemic levels of PH. The patency was also ex-
amined by direct vision of the anastomosis lumen. Despite
overt intimal hyperplasia in the LEJV in sporadic cases, the
cervical shunts were all still patent.
Blood Gas Analysis
Compared with the RPALG, LCSG, and SOG, a signifi-
cant decrement in the partial arterial pressure of oxygen
and a slight increment in the hemoglobin and hematocrit
were progressively present in the CSG as the disorder
advanced (Table E1).
In Vivo Hemodynamic Evaluation
Immediate effect. Immediately after cervical surgery, the
RVSP, PASP, and mPAP in the CSG were dramaticallydiovascular Surgery c Volume 146, Number 5 1223
FIGURE 4. Plot showing rats in combined surgery group (CSG) have in-
creasedmedial thickness of arteries or arterioles less than125mmin external
diameter. Histopathologic analysis revealed significant medial hypertrophy
in intra-acinar arteries of 25 to 75 mm in external diameter and pervasive re-
currence of smooth muscle layer in peripheral arterioles less than 25 mm in
external diameter in CSG. Moreover, compared to 8-week value, extent of
right ventricular hypertrophy index (RVHI) in CSG at 12 weeks was aggra-
vated in arteries or arterioles less than 125mmin external diameter. Data pre-
sented as mean standard deviation. *P<.05 versus sham operation group
(SOG), **P<.01 versus SOG, xP<.05 versus CSG at 8 weeks postopera-
tively, xxP<.01 versus CSG at 8 weeks postoperatively, NSP>.05 versus
CSG at 8 weeks postoperatively.CSG-8W,CSG at 8 weeks postoperatively;
CSG-12W, CSG at 12 weeks postoperatively.
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in the RVSP, PASP, and mPAP, although these were still
greater than the corresponding normal levels (Figure 3
and Table E2). This finding could be interpreted as the com-
bined surgery resulting in a prompt, persistent, and revers-
ible increment in pulmonary arterial pressure.
Chronic effect. As demonstrated in Figure 3, A-C, and
Table E2, the mean values for the RVSP, PASP, and mPAP
of the CSG manifested a prominent and consistent time-
related increment compared with the remaining groups.
Completely clamping the shunt in the CSG induced a signif-
icant decrease in the RVSP, PASP, and mPAP at 8 weeks,
although the levels remained much greater than those of
the SOG. Although a reduction in cardiac output from clos-
ing the shunt might play a role in the decrease, considering
the pulmonary vasculopathy at 8 weeks in the CSG
(Figure 5), the PH status still possessed a reversible charac-
teristic at 8 weeks postoperatively. Cervical shunt occlusion
also induced a reduction in these hemodynamic variables
at 12 weeks in the CSG, but most of these decreases failed
to reach a statistically significant difference, confirming
an approximate demarcation of the reversibility of the grad-
ual remodeling of the pulmonary vasculature.
However, completely clamping the cervical shunt in the
LCSG resulted in regression of the hemodynamic indexes
to the normal levels of the SOG at 12 weeks (Figure 3, A-
C), suggesting that the pulmonary vasculature was still in
a reversible condition.
Right Ventricular Hypertrophy Index
RVHI increased in a time-related manner in the RPALG,
LCSG, and CSG compared with that of the SOG (Table E2
and Figure 3, D). Although the right ventricular hypertro-
phy in the CSG was more severe than that in the RPALG
and LCSG and a significant difference in the RVHI was
present between the CSG and the RPALG and LCSG, no
statistically significant difference was found between the
RPALG and LCSG in the RVHI.
Morphologic Analysis of Pulmonary Vasculature
As demonstrated in Figure 4, the pulmonary vasculature
in the CSG was extensively remodeled at the levels of the
arteries less than 125 mm in external diameter compared
with the pulmonary vasculature of the SOG. Histopatho-
logic analysis revealed significant medial hypertrophy in
the intra-acinar arteries 25 to 75 mm in external diameter
and a pervasive recurrence of the smooth muscle layer in
the peripheral arterioles less than 25 mm in external diame-
ter in the CSG. Moreover, compared with the SOG, the
vessel muscularization in the CSG was progressively exac-
erbated in terms of the number of vessels having a full or
partial muscular wall at all levels.
Furthermore, a striking spectrum of pulmonary remodel-
ing lesions gradually presented with the deterioration of1224 The Journal of Thoracic and Cardiovascular Surthis disorder in the CSG. The predominant reversible
changes—muscularization and cellular intimal prolifera-
tion—had emerged by 8 weeks postoperatively and were
progressively exacerbated into irreversible vascular
lesions—intimal fibrosis and entire luminal occlusion—by
12 weeks postoperatively. Representative images from the
CSG and SOG are shown in Figure 5.
Consistent with the hemodynamic data, no apparent vas-
cular remodeling was observed in the SOG, although
medial hypertrophy was present in the small pulmonary
arteries in the RPALG and LCSG at 8 weeks postopera-
tively. However, this slight vascular remodeling lesion
was not aggravated at 12 weeks in terms of the percentage
of MTand also did not extend into the peripheral arterioles.
DISCUSSION
In the present study, we successfully established a novel
rat model of PH to closely reproduce the aberrant hemody-
namic status and characteristic morphologic changes
observed in the lungs of patients with intracardiac shunts.
Congenital intracardiac shunts consequently result in PH
and, eventually, Eisenmenger syndrome, if left without sur-
gical correction. In some cases, even with surgical correc-
tion, the exaggerated pulmonary vascular vasospasm
frequently provokes postoperative pulmonary hypertensive
crisis, which inevitably increases mortality. Although thegery c November 2013
FIGURE 5. Representative morphologic images of lungs from sham operation group (SOG) and combined surgery group (CSG). A-D, Pulmonary arteries
and arterioles less than 50 mm from SOG with normal morphology. Pulmonary arteries and arterioles less than 50 mm from CSG at 8 weeks with E,
muscularization, F, cellular intimal proliferation, and G, H, neointima formation. Pulmonary arteries and arterioles less than 50 mm from CSG at 12 weeks
showing I, muscularization, J, cellular vascular occlusion, and K, intimal fibrosis and L, entire luminal occlusion. CSG-8W,CSG at 8 weeks postoperatively;
CSG-12W, CSG at 12 weeks postoperatively.
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sels have been previously described in detail,5 the progres-
sion of reversible lesions to irreversible lesions has never
been successfully reproduced in ratswith left-to-right shunts.
The classic hypoxia/monocrotaline-induced PH models
have deduced numerous cellular and molecular mecha-
nisms of PH. However, their easy and reproducible merits
would not negate that the hypoxia/monocrotaline-induced
PH has been attributed, to a large extent, to the sustained
vasoconstriction.15-17 In particular, no occlusive intimal
lesions emerged in the peripheral pulmonary arteries/arte-
rioles, let alone the loss of pulmonary microvessels.17-19
Furthermore, recent clinical trials1 have shown that mono-
therapy or combination therapy using targeted drugs
exerted preventive, or even reversible, efficacy on
hypoxia/monocrotaline-induced PH.20,21 However, none
resulted in significantly lower mortality in patients with
severe PH. This disappointing discrepancy has meant that
researchers must reconsider the incompetence and
limitations of hypoxia/monocrotaline-induced PH.22-24
Also, investigators evaluating new therapies for PH
should adopt an alternative PH model.
Continuous attempts have been made to simulate the pul-
monary vasculopathy by surgically creating peripheral or
central systemic-to-pulmonary communication.4-8,10
Although the pulmonary circulation is relatively well
tolerant to peripheral shunts,4-6 the limited increase inThe Journal of Thoracic and Carpulmonary blood flow unavoidably results in too little or
only medial hypertrophy changes in the pulmonary
arteries (grade 1). Central shunts prepared in large
animals7,8,10 closely simulate the pathophysiologic
characteristics of congenital intracardiac shunts; however,
the high-level surgical requirements, relatively greater mor-
tality,10 limited potency in inducing remodeling lesions,7
and inadequacy of biochemical reagents for large animals
have impeded the widespread adoption of these models.
Thus, a satisfactory shunt-related model that could be used
to determine the underlying molecular mechanisms of pul-
monary vascular remodeling due to in vivo exposure to
high blood flow is still needed. Therefore, it is critically im-
portant to create an experimentally validated shunt model.
In the present study, we first found the anatomic discrep-
ancy between the bilateral lungs in the SD rats, which pro-
vided an advantage in generating the shunt model. With this
finding and 2 extant surgical procedures used in creating
flow-associated PH (ie, cervical shunt4 and pulmonary
artery ligation11), we created an original rat model of high
kinetic unilateral PH. Although 1 lung was excluded from
the pulmonary circulation, and this could generate a ventila-
tion/perfusion mismatch, as demonstrated by the blood gas
analysis results in the RPALG (Table E1), the remaining left
lung was relatively tolerant to the increased pulmonary
blood flow and could maintain a satisfactory balance
between oxygen supply and expenditure.diovascular Surgery c Volume 146, Number 5 1225
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RPALG, this 2-stage procedure did result in striking eleva-
tions of the RVSP, PSAP,mPAP, andRVHI, with surprisingly
low mortality in the CSG. Furthermore, these hemodynamic
changes were partially reversible immediately and 8 weeks
after the 2-stage surgery andgradually progressed to irrevers-
ible lesions by 12 weeks postoperatively. Consistent with the
hemodynamic changes, after the cervical surgery in theCSG,
reversible changes in the pulmonary vasculature (ie, medial
hypertrophy and cellular intimal reaction) had occurred at
8 weeks and gradually progressed into boundary lesions
(excessively cellular intimal proliferation) and finally to irre-
versibly acellular intimal fibrosis and total luminal occlusion
by 12weeks (Figure 5). Taken together, we can conclude that
the pulmonary vascular remodeling induced by this original
model experienced a transition from reversibility at 8 weeks
to irreversibility by 12 weeks.
Some limitations of the present study should be clarified.
The cuff technique used in the cervical procedure might dis-
allow for shunt flow to progressively and concomitantly aug-
ment in growing rats. Thus, the true potential of this model
and the extent of PHmight have been inadvertently underes-
timated. This could be another explanation for the absent
concentric laminar intimal fibrosis and plexiform lesions,
except for extrapolating from the relatively short observa-
tion time. No long-term analysis after shunt closurewas per-
formed to observe the effect on the pulmonary vasculopathy.
CONCLUSIONS
We have presented an original unilateral PHmodel in rats
based on their inherent discrepancy between the bilateral
lungs. This model provides an alternative for investigations
directed at elucidating the underlying mechanisms respon-
sible for pulmonary vasculopathy, especially the switch
from reversibility to irreversibility.
Special gratitude should be given to Professor Yue Tang, Peihe
Wang, Liujun Jia, and Fuliang Luo for their technical assistance.
References
1. Bai Y, Sun L, Hu S, Wei Y. Combination therapy in pulmonary arterial hyperten-
sion: a meta-analysis. Cardiology. 2011;120:157-65.
2. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM,
et al. Cellular and molecular pathobiology of pulmonary arterial hypertension.
J Am Coll Cardiol. 2004;43(12 suppl S):13S-24S.
3. Voelkel NF, Tuder RM, Weir EK. Pathophysiology of primary pulmonary hyper-
tension. In: Rubin L, Rich S, eds. Primary pulmonary hypertension. New York:
Marcel Dekker; 1997:83-129.1226 The Journal of Thoracic and Cardiovascular Sur4. Xiong M, Yao JP, Wu ZK, Liao B, Liang YJ, Zhang X, et al. Fibrosis of pulmo-
nary vascular remodeling in carotid artery–jugular vein shunt pulmonary artery
hypertension model of rats. Eur J Cardiothoracic Surg. 2012;41:162-6.
5. Li XH, Jin HF, Bin G, Wang L, Tang C, Du J. Endogenous hydrogen sulfide reg-
ulates pulmonary artery collagen remodeling in rats with high pulmonary blood
flow. Exp Biol Med. 2009;234:504-12.
6. Fullerton DA, Mitchell MB, Jone DN, Maki A, McIntyre RC Jr. Pulmonary
vasomotor dysfunction is produced with chronically high pulmonary blood
flow. J Thorac Cardiovasc Surg. 1996;111:190-7.
7. Rondelet B, Dewachter C, Kerbaul F, Kang X, Fesler P, Brimioulle S, et al. Pro-
longed overcirculation-induced pulmonary arterial hypertension as a cause of
right ventricular failure. Eur Heart J. 2012;33:1017-26.
8. WangW, Liu R, Cao G, Zhang F, Zhang Y, Zhang Z, et al. A reliable rabbit model
for hyperkinetic pulmonary hypertension. J Thorac Cardiovasc Surg. 2010;140:
395-9.
9. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy
in congenital heart disease: a morphometric approach to vascular disease. Circu-
lation. 1978;58:1107-22.
10. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, et al. In
utero placement of aorta pulmonary shunts: a model of postnatal pulmonary
hypertension with increased pulmonary blood flow in lambs. Circulation.
1995;92:606-13.
11. Gorenflo M, Herpel E, Ullmann MV, Rohlig K, Demirakca S, Klimpel H, et al.
Pulmonary vascular changes in piglets with increased pulmonary blood flow
and pressure. Virchow Arch. 2007;450:643-52.
12. Sun P, LiuWL.Method for measuring pulmonary artery pressure by right cardiac
catheter in rats. Acta Acad Med Sin. 1984;6:465-7.
13. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular dis-
ease: a description of six grades of structural changes in the pulmonary arteries
with special reference to congenital cardiac septal defects. Circulation. 1958;
18:533-47.
14. Wagenvoort CA. Open lung biopsies in congenital heart disease for evaluation of
pulmonary vascular disease: predictive value with regard to corrective operabil-
ity. Histopathology. 1985;9:417-36.
15. Wagenvoort CA, Wagenvoort N, Draulans-Noe Y. Reversibility of plexogenic
pulmonary arteriopathy following banding of the pulmonary artery. J Thorac
Cardiovasc Surg. 1984;87:876-86.
16. Oka M, Fagan KA, Jones PL, McMurtry IF. Therapeutic potential of rhoa/rho
kinase inhibitors in pulmonary hypertension. Br J Pharmacol. 2008;155:444-54.
17. Tenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in
chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res.
2005;97:95-8.
18. McLoughlin P, McMurtry I. Counterpoint: chronic hypoxia-induced pulmonary
hypertension does not lead to loss of pulmonary vasculature. J Appl Physiol.
2007;103:1451-3; discussion 1453-4.
19. Rabinovitch M, Chesler N, Molthen RC. Point: counterpoint: chronic hypoxia-
induced pulmonary hypertension does/does not lead to loss of pulmonary vascu-
lature. J Appl Physiol. 2007;103:1449-51.
20. Itoh T, Nagaya N, Fujii T, Iwase T, Nakanishi N, Hamada K, et al. A combination
of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am
J Respir Crit Care Med. 2004;169:34-8.
21. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, et al.
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryp-
tamine transporter gene. J Clin Invest. 2000;105:1555-62.
22. Bauer NR, Moore TM, McMurtry IF. Rodent models of PAH: are we there yet?
Am J Physiol Lung Cell Mol Physiol. 2007;293:L580-2.
23. Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling:
a model for what human disease? J Clin Invest. 2000;106:733-8.
24. Zaiman A, Fijalkowska I, Hassoun PM, Tuder RM. One hundred years of
research in the pathogenesis of pulmonary hypertension. Am J Respir Cell Mol
Biol. 2005;33:425-31.gery c November 2013
TABLE E1. Weight gain and oxygenation indexes
Variable Weight gain (g)
Arterial blood gas parameters
PaO2 (mm Hg) SaO2 (%) Hb (g/dL) Hct (%)
RPALG
8W (n ¼ 8) 527.43  33.71 95.27  3.49 97.04  2.25 13.59  1.36 42.30  2.39
12W (n ¼ 8) 570.33  25.84 92.08  4.63 94.34  3.38 15.16  0.93 45.37  1.80
LCSG
8W (n ¼ 8) 537.02  26.39 101.34  5.09 98.17  1.25 12.81  2.03 45.83  1.71
12W (n ¼ 8) 589.48  35.01 98.08  3.72 97.39  1.83 13.29  1.27 43.04  1.94
CSG
IM (n ¼ 8) 267.19  17.21 101.83  5.53 98.15  0.59 13.73  0.44 43.25  2.95
8W (n ¼ 9) 488.89  28.03 88.18  2.98 96.54  1.61 14.59  0.92 43.38  3.78
12W (n ¼ 12) 549.33  36.96 87.01  4.06 96.65  0.63 15.00  0.55 44.91  1.62
SOG
8W (n ¼ 11) 541.63  29.67 104.89  6.06 97.92  0.69 13.92  1.09 41.70  3.29
12W (n ¼ 12) 585.34  47.87 100.98  7.25 98.36  0.76 13.62  1.42 43.19  2.12
Data presented as mean standard deviation. PaO2, Partial arterial pressure of oxygen; SaO2, blood oxygen saturation; Hb, hemoglobin concentration; Hct, hematocrit; RPALG,
right pulmonary artery ligation group; 8W, 8 weeks postoperatively; 12W, 12 weeks postoperatively; LCSG, left cervical shunt group; CSG, combined surgery group; IM,
immediately postoperatively; SOG, sham operation group.
TABLE E2. Right ventricular hypertrophy index and general hemodynamics before and after shunt closure
Variable RVHI (%)
Hemodynamics (before/after shunt occlusion)
RVSP (mm Hg) PASP (mm Hg) mPAP (mm Hg)
RPALG
8W (n ¼ 8) 32.83  4.79 33.62  9.53 31.77  8.19 20.85  4.51
12W (n ¼ 8) 35.39  6.04 40.51  8.37 38.55  5.76 23.39  5.40
LCSG
8W (n ¼ 8) 33.87  4.41 34.15  8.34/28.46  5.38 32.15  4.58/27.31  6.29 22.46  4.38/19.50  3.29
12W (n ¼ 8) 37.31  5.39 39.69  5.94/31.81  7.14 37.90  7.41/30.28  3.32 27.13  6.67/21.38  4.57
CSG
IM (n ¼ 8) 30.10  3.17 45.72  6.02/37.85  7.05 43.90  5.05/33.71  1.75 25.92  1.43/22.62  2.12
8W (n ¼ 8) 51.83  7.41 61.62  11.33/52.30  11.21 57.77  11.81/50.17  11.33 35.03  7.78/32.65  6.59
12W (n ¼ 10) 62.88  7.65 67.51  11.20/63.76  8.53 62.55  11.52/58.50  7.10 36.84  4.81/34.31  2.95
SOG
8W (n ¼ 11) 29.45  1.29 27.62  3.24/29.07  2.36 24.92  3.23/26.01  2.57 18.09  1.43/19.21  1.74
12W (n ¼ 12) 28.36  2.48 28.31  1.73/27.91  3.17 26.07  2.47/27.39  3.16 17.75  1.59/18.53  2.12
All data presented as mean standard deviation. RVHI,Right ventricular hypertrophy index;RVSP, right ventricular systolic pressure; PASP, pulmonary arterial systolic pressure;
mPAP,mean pulmonary arterial pressure; RPALG, right pulmonary artery ligation group; 8W, 8 weeks postoperatively; 12W, 12 weeks postoperatively; LCSG, left cervical shunt
group; CSG, combined surgery group; IM, immediately postoperatively; SOG, sham operation group.
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